Total percutaneous biventricular assist device implantation for fulminant myocarditis
Yuji Tominaga(The University of Osaka), Yoshiki Sawa(Osaka Police Hospital), Shigeru Miyagawa(The University of Osaka), Yasushi Sakata(Osaka University), Kei Nakamoto(The University of Osaka), Satoshi Kainuma(National Cerebral and Cardiovascular Center), Ai Kawamura(Max Planck Institute for Heart and Lung Research), Takuji Kawamura(The University of Osaka), Daisuke Yoshioka(The University of Osaka), Köichi Toda(The University of Osaka)
Cited by 13
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|599
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363